CUSTOMIZE: overall results from a hybrid III implementation-effectiveness study examining implementation of cabotegravir and rilpivirine long-acting injectable for HIV treatment in US healthcare settings; final patient and provider data

M. Czarnogorski, C. Garris,R. D'Amico, J. Flamm,G. Sinclair, M. Wohlfeiler, L. Mena, M. Dalessandro,C. McHorney, S. Mansukhani,W. Williams, D. Merrill,W. Spreen

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2021)

引用 12|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要